ReviewThe British journal of radiology2024
State-of-the-art for contrast-enhanced mammography.
Review in The British journal of radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Practical Guide to Percutaneous Biopsy with Contrast-Enhanced Mammography: From Planning to Post-Procedural Management.Diagnostics (Basel, Switzerland) · 2026Review
- Article
- How Does ACR BI-RADSDiagnostics (Basel, Switzerland) · 2026Review
- Clinical Applications and Decision-Making Impact of Contrast-Enhanced Mammography and MRI: A Recent Structured Review.Diagnostics (Basel, Switzerland) · 2026Review
- Time to reconsider the role of contrast-enhanced mammography in work-up after screening?European radiology · 2026Article
- Effectiveness of Contrast-Enhanced Spectral Mammography Following Contrast-Enhanced Computed Tomography in Breast Cancer Diagnosis.Diagnostics (Basel, Switzerland) · 2026Article
- Imaging Ductal Carcinoma In Situ in the Era of De-Escalation: Role, Limits, and Clinical Implications for Risk-Adapted Management.Diagnostics (Basel, Switzerland) · 2026Review
- Diagnostic value of contrast-enhanced spectral mammography for breast lesions: qualitative and quantitative analyses.Quantitative imaging in medicine and surgery · 2026Article
- Evolving Role of Contrast-Enhanced Mammography-Guided Biopsy: Clinical Value and Limitations.Korean journal of radiology · 2026Article
- Ground-Glass Enhancement on Contrast-Enhanced Mammography: A CT-Inspired Qualitative Descriptor for Breast Lesion Characterization.Journal of clinical medicine · 2026Article
- Explainable Deep Learning for Breast Lesion Classification in Digital and Contrast-Enhanced Mammography.Diagnostics (Basel, Switzerland) · 2025Article
- Achieving single-contrast administration for enhanced chest CT and contrast-enhanced spectral mammography without compromising diagnostic quality: a comparative study.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025Article
- Deep-learning prediction of breast cancer hormone receptor status from CEM: a preliminary study.European radiology experimental · 2025Article
- Contrast-enhanced mammography-guided biopsy: principles, challenges, and opportunities.Insights into imaging · 2025Review
- 조영증강 유방촬영술: 현재의 임상적 활용과 미래 방향에 대한 종합적 고찰.Journal of the Korean Society of Radiology · 2025Review
- Improving the diagnostic performance of contrast-enhanced mammography through lesion conspicuity and enhancement quantification.European radiology · 2025Article
- Evaluation of contrast-enhanced mammography (CEM) in the preoperative staging of breast cancer: large-scale single center experience, update to 1005 cases.La Radiologia medica · 2025Article
- Contrast-enhanced mammography vs MRI: Which breast imaging modality leads in lesion detection?European radiology · 2025Article
- Emerging nanoparticle-based x-ray imaging contrast agents for breast cancer screening.Nanomedicine (London, England) · 2025Review
- Morphodynamic Features of Contrast-Enhanced Mammography and Their Correlation with Breast Cancer Histopathology.Journal of imaging · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Contrast-enhanced mammography (CEM) is an emerging breast imaging technology with promise for breast cancer screening, diagnosis, and procedural guidance. However, best uses of CEM in comparison with other breast imaging modalities such as tomosynthesis, ultrasound, and MRI remain inconclusive in many clinical settings. This review article summarizes recent peer-reviewed literature, emphasizing retrospective reviews, prospective clinical trials, and meta-analyses published from 2020 to 2023. The intent of this article is to supplement prior comprehensive reviews and summarize the current state-of-the-art of CEM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.